Gene · 780
Papers2,465
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
401 to 420 of 2,465
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Cellular Dormancy in Cancer: Mechanisms and Potential Targeting Strategies. | Cancer Res Treat | 2023 | 36960624 | PubTator, text mining | PubMed |
| Biological functions, mechanisms, and clinical significance of circular RNA in colorectal cancer. | Front Oncol | 2023 | 36950552 | PubTator, text mining | PubMed |
| Treatment update for vitiligo based on autoimmune inhibition and melanocyte protection. | Expert Opin Ther Targets | 2023 | 36947026 | PubTator, text mining | PubMed |
| Patient-derived podocyte spheroids reveal new insights into the etiopathogenesis of Alport syndrome. | Front Cell Dev Biol | 2023 | 36936689 | PubTator, text mining | PubMed |
| Genetic susceptibility to severe COVID-19. | Infect Genet Evol | 2023 | 36934789 | PubTator, text mining | PubMed |
| Overcoming the imatinib-resistant BCR-ABL mutants with new ureidobenzothiazole chemotypes endowed with potent and broad-spectrum anticancer activity. | J Enzyme Inhib Med Chem | 2023 | 36927348 | PubTator, text mining | PubMed |
| Single-Cell and Transcriptome-Based Immune Cell-Related Prognostic Model in Clear Cell Renal Cell Carcinoma. | J Oncol | 2023 | 36925653 | PubTator, text mining | PubMed |
| A variability in response of osteoclasts to zoledronic acid is mediated by smoking-associated modification in the DNA methylome. | Clin Epigenetics | 2023 | 36915112 | PubTator, text mining | PubMed |
| Footprints: Stamping hallmarks of lung cancer with patient-derived models, from molecular mechanisms to clinical translation. | Front Bioeng Biotechnol | 2023 | 36911198 | PubTator, text mining | PubMed |
| Recent progress in targeted therapy for non-small cell lung cancer. | Front Pharmacol | 2023 | 36909198 | PubTator, text mining | PubMed |
| Extracellular matrix remodeling in tumor progression and immune escape: from mechanisms to treatments. | Mol Cancer | 2023 | 36906534 | PubTator, text mining | PubMed |
| The Chemopreventive Effects of Chlorogenic Acids, Phenolic Compounds in Coffee, against Inflammation, Cancer, and Neurological Diseases. | Molecules | 2023 | 36903626 | PubTator, text mining | PubMed |
| Vitiligo, from Pathogenesis to Therapeutic Advances: State of the Art. | Int J Mol Sci | 2023 | 36902341 | PubTator, text mining | PubMed |
| COL12A1 Acts as a Novel Prognosis Biomarker and Activates Cancer-Associated Fibroblasts in Pancreatic Cancer through Bioinformatics and Experimental Validation. | Cancers (Basel) | 2023 | 36900272 | PubTator, text mining | PubMed |
| Publisher Correction: Collagenolysis-dependent DDR1 signalling dictates pancreatic cancer outcome. | Nature | 2023 | 36882540 | PubTator, text mining | PubMed |
| A case of neonatal osteofibrous dysplasia with novel CDK12 and DDR2 mutations. | Bone Rep | 2023 | 36875508 | PubTator, text mining | PubMed |
| Identification of m6A/m5C/m1A-associated LncRNAs for prognostic assessment and immunotherapy in pancreatic cancer. | Sci Rep | 2023 | 36871072 | PubTator, text mining | PubMed |
| Cancer immune evasion through KRAS and PD-L1 and potential therapeutic interventions. | Cell Commun Signal | 2023 | 36864508 | PubTator, text mining | PubMed |
| Biochemical Studies of Systemic Lupus Erythematosus-Associated Mutations in Nonreceptor Tyrosine Kinases Ack1 and Brk. | Biochemistry | 2023 | 36854171 | PubTator, text mining | PubMed |
| Molecular and functional imaging in cancer-targeted therapy: current applications and future directions. | Signal Transduct Target Ther | 2023 | 36849435 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/780/papers?page=21